A case of akathisia induced by Escitalopram: Case report & review of literature

Current Drug Safety

Volumn 9, Issue 1, 2014, Pages 56-59

  Basu, Bishan ^a   Gangopadhyay, Tanmoy ^a   Dutta, Nivedita ^b   Mandal, Bidyut ^a   De, Sumitava ^a   Mondal, Srikrishna ^a  

^a BANKURA SAMMILANI MEDICAL COLLEGE   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Drug induced akathisia; Escilopram induced EPS; SSRI induced Akathisia; SSRI induced EPS

Indexed keywords

CLONAZEPAM; ESCITALOPRAM; HORMONE RECEPTOR; PROPRANOLOL;

ADULT; AKATHISIA; ANXIETY; ARTICLE; BARNES AKATHISIA SCALE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL ASSESSMENT; DECREASED APPETITE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ESCITALOPRAM INDUCED AKATHISIA; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; METASTASIS; MIDDLE AGED; MITRAL VALVE PROLAPSE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RESTLESSNESS; SUICIDAL IDEATION; THYROID DISEASE; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BREAST NEOPLASMS; CITALOPRAM; CLONAZEPAM; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; PROPRANOLOL; PSYCHOMOTOR AGITATION; SEROTONIN UPTAKE INHIBITORS;

EID: 84895429819     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488630901140224104651     Document Type: Article

References (36)

1. Akagi H, Kumar, TM. Akathisia: Overlooked at a cost. BMJ 2002; 324: 1506-1507.
2. Barnes, TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-676.
3. Horiguchi J, Nishimatsu O, Inami Y. Successful treatment with clonazepam for neuroleptic-induced akathisia. Acta Psychiatr Scand 1989; 80: 106-107.
4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
5. Albayrak Y, Ugurlu GK, Ekinci O, Caykoylu, Çayköylü A. Escilaopram-induced Severe Akathisia: A Case Report. Prim Care Companion J Clin Psychiatry 2010; 12(6): PCC.10l01016.
6. Koliscak LP, Makela EH. Selective serotonin reuptake inhibitorinduced akathisia. J Am Pharm Assoc 2009; 49(2): e28-38.
7. Lipinski JF Jr, Mallya G, Zimmerman P, et al. Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 1989; 50(9): 339-342.
8. Macgillivray L, Reynolds KB, Sickand M, Rosebush PI, Mazurek MF. Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 2011; 65: 1166-1172.
9. Baldessarini RJ. In: Drug Therapy of Depression & Anxiety Disorders in Goodman & Gilman's The Pharmacological Basis of Therapeautics-11th Ed. Medical Publishing Division 2006.
10. Foster AR, Lancaster NP. Disturbance of motor function during treatment with imipramine. Br Med J 1959; 2: 1452-1453.
11. Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants-A review of the literature and an analysis of spontaneous reports. Ann Clin Psychiatry 2010; 22(3): 148-156.
12. Meltzer HY, Young M, Metz J, et al. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm 1979; 45: 165-175.
13. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449-454.
14. Gerber PE, Lynd LD. Selective serotonin-reuptake inhibitorinduced movement disorders. Ann Pharmacother 1998; 32: 692-698.
15. Gill HS, DeVane CL, Risch SC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: A review of the literature and consolidating hypotheses. J Clin Psychopharmacol 1997; 17: 377-389.
16. Schillevoort I, van Puijenbroek EP, de Boer A, et al. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol 2002; 17: 75-79.
17. Wils V. Extrapyramidal symptoms in a patient treated with fluvoxamine. J Neurol Neurosurg Psychiatry 1992; 55: 330-331.
18. LaPorta LD. Sertraline-induced akathisia. J Clin Psychopharmacol 1993; 13: 219-220.
19. Shihabuddin L, Rapport D. Sertraline and extrapyramidal side effects. Am J Psychiatry 1994; 151: 288.
20. Kölling P, Jansen SEN, de Burlet HM. Extrapyramidal disorders following sertraline use; experiences with a new selective antidepressant. Ned Tijdschr Geneeskd 1996; 140: 1467-1468.
21. Lambert MT, Trutia C, Petty F. Extrapyramidal adverse effects associated with sertraline. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 741-748.
22. Madhusoodanan S, Brenner R. Reversible choreiform dyskinesia and extrapyramidal symptoms associated with sertraline therapy. J Clin Psychopharmacol 1997; 17: 138-139.
23. Muldoon C. The safety and tolerability of citalopram. Int Clin Psychopharmacol 1996; 11: 35-40.
24. Najjar F, Price LH. Citalopram and dystonia. J Am Acad Child Adolesc Psychiatry 2004; 43: 8-9.
25. Wise M. Citalopram-induced bruxism. Br J Psychiatry 2001; 178: 182.
26. Parvin MM, Swartz CM. Dystonic rabbit syndrome from citalopram. Clin Neuropharmacol 2005; 28: 289-291.
27. Duggal HS, Mendhekar DN. A case report of reemergence of antipsychotic-induced dyskinesia with citalopram. J Clin Psychiatry 2007; 68: 803.
28. Stadtland C, Erfurth A, Arolt VD. De novo onset of Parkinson's disease after antidepressant treatment with citalopram. Pharmacopsychiatry 2000; 33(5): 194-195.
29. Miletić V, Relja M. Citalopram-induced parkinsonian syndrome: case report. Clin Neuropharmacol 2011; 34(2): 92-93.
30. Birthi P, Walters C, Karandikar N. A rare case of tardive dyskinesia and akathisia induced by citalopram. PMR 2010; 2(10): 973-975.
31. Garcia RPJ, Cabo I, Bermejo PG, et al. Escitalopram-induced paroxysmal dystonia. Clin Neuropharmacol 2007; 30: 124-126.
32. Patel OP, Simon MR. Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine. Int Arch Allergy Immunol 2006; 140: 27-29.
33. Page RL, Ruscin JM, Bainbridge JL, Brieke AA. Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacother 2008; 28(2): 271-280.
34. Park YM, Lee HJ, Kang SG, Choo CS, Cho JH. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(2): 380-381.
35. Muthusami S, Basu S, Kumar A, Dash A. Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram. J Child Adolesc Psychopharmacol 2009; 19(3): 317-318.
36. Hirose S. The causes of underdiagnosing akathisia. Schizophrenia Bulletin 2003; 29(3): 547-558.